Current through October 31, 2024
Rule 15-16-1-41.83.24 - Required Laboratory Capabilities The medical director of the FED and the director of laboratory services shall develop guidelines for availability and timeliness of services for the FED. The following laboratory capabilities are required for the FED. This list may not be comprehensive or complete.
1. Blood bank a. Bank products availability b. Type and cross-matching capabilities 2. Chemistry c. Anticonvulsant and other therapeutic drug levels e. Bilirubin (total and direct) h. Cardiac isoenzymes (including creatine kinase-MB) i. Chloride (blood and cerebrospinal fluid [CSF]) m. Glucose (blood and CSF) n. Liver-function enzymes (ALT, AST, alkaline phosphatase) 3. Hematology a. Cell count and differential (blood, CSF, and joint fluid analysis) c. Erythrocyte sedimentation rate 4. Microbiology a. Acid fast smear/staining c. Counter immune electrophoresis for bacterial identification d. Gram staining and culture/sensitivities 5. Other c. Prothrombin Time (PT)/International Normalized Ratio (INR), Partial Thromboplastin Time (PTT) d. Joint fluid and CSF analysis e. Toxicology screening and drug levels h. Serology (syphilis, recombinant, immunoassay) i. Pregnancy testing (qualitative and quantitative) 15 Miss. Code. R. 16-1-41.83.24
Miss. Code Ann. § 41-75-13